Alirocumab addition to statins fails to improve endothelial function in acute MI patients: PACMAN-AMI trial substudy
Switzerland: In a significant development in cardiovascular medicine, findings from a substudy of the PACMAN-AMI randomized clinical trial shed light on the potential benefits of alirocumab in...
Source: medicaldialogues.in